Novel JAK-1 inhibitor upadacitinib as a possible treatment for refractory SAPHO syndrome: A case report

Int J Rheum Dis. 2023 Nov;26(11):2335-2337. doi: 10.1111/1756-185X.14774. Epub 2023 Jun 7.
No abstract available

Keywords: SAPHO syndrome; autoinflammatory disease; treatment option; upadacitinib.

Publication types

  • Letter

MeSH terms

  • Acquired Hyperostosis Syndrome* / diagnosis
  • Acquired Hyperostosis Syndrome* / drug therapy
  • Heterocyclic Compounds, 3-Ring / therapeutic use
  • Humans
  • Janus Kinase Inhibitors* / therapeutic use

Substances

  • upadacitinib
  • Heterocyclic Compounds, 3-Ring
  • Janus Kinase Inhibitors